Table 5 Association between KU‐MEL‐1 specific serum IgG Ab and various clinicopathological features in VKH patients.
| Clinical features and genotype | KU‐MEL‐1 (+) | KU‐MEL‐1 (−) | p Value | |
|---|---|---|---|---|
| Age (mean (SD)) | 44.7 (15.1) | 40.2 (10.0) | ||
| Sex | Male | 12/13 (92%) | 1/13 (8%) | <0.05† |
| Female | 10/22 (45%) | 12/22 (55%) | ||
| Critical pattern | Initial onset | 20/30 (67%) | 10/30 (33%) | 0.52† |
| Recurrence | 2/5 (40%) | 3/5 (60%) | ||
| SRD* | Positive | 20/29 (69%) | 9/29 (31%) | 0.24† |
| Negative | 2/6 (33%) | 4/6 (67%) | ||
| Pleocytosis | Positive | 17/26 (65%) | 9/26 (35%) | 1.00† |
| Negative | 5/7 (71%) | 2/7 (29%) | ||
| HLA‐DRB1*0405 | Positive | 19/25 (76%) | 6/25 (24%) | <0.05† |
| Negative | 3/10 (30%) | 7/10 (70%) | ||
*Serous retinal detachment.
†Fisher's exact probability test.